Zdrowie i gospodarka · 14/12/2009

FDA Approves New Injectable Insulin Treatment for Cats with Diabetes

The Food and Drug Administration (FDA) is updating its animal drug regulations to reflect the approval of a new insulin treatment for cats with diabetes, developed by Boehringer Ingelheim Vetmedica, Inc. The new treatment, an injectable suspension of protamine zinc recombinant human insulin, is intended to reduce hyperglycemia and related symptoms in cats with diabetes.